Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells.
Ectopic lipids in peripheral tissues have been implicated in attenuating insulin action in vivo. The botanical extract of Artemisia dracunculus L. (PMI 5011) improves insulin action, yet the precise mechanism is not known. We sought to determine whether the mechanism by which PMI 5011 improves insulin signaling is through regulation of lipid metabolism. After differentiation, cells were separately preincubated with free fatty acids (FFAs) and ceramide C2, and the effects on glycogen content, insulin signaling, and ceramide profiles were determined. The effect of PMI 5011 on ceramide accumulation and ceramide-induced inhibition of insulin signaling was evaluated. FFAs resulted in increased levels of total ceramides and ceramide species in L6 myotubes. Saturated FFAs and ceramide C2 inhibited insulin-stimulated phosphorylation of protein kinase B/Akt and reduced glycogen content. PMI 5011 had no effect on ceramide formation or accumulation but increased insulin sensitivity via restoration of Akt phosphorylation. PMI 5011 also attenuated the FFA-induced upregulation of a negative inhibitor of insulin signaling, i.e., protein tyrosine phosphatase 1B (PTP1B), and increased phosphorylation of PTP1B. PMI 5011 attenuates the reduction in insulin signaling induced by ceramide accumulation, but the mechanism of improved insulin signaling is independent of ceramide formation.
Botanical Research Center, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, USA.
Diana N
DN
Obanda
Amy
A
Hernandez
David
D
Ribnicky
Yongmei
Y
Yu
Xian H
XH
Zhang
Zhong Q
ZQ
Wang
William T
WT
Cefalu
D000818:Animals; D002478:Cells, Cultured; D002518:Ceramides / Q000096:biosynthesis / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology; D006003:Glycogen / Q000032:analysis; D007328:Insulin / Q000494:pharmacology*; D018482:Muscle, Skeletal / Q000378:metabolism*; D010936:Plant Extracts / Q000494:pharmacology*; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1 / Q000502:physiology; D051381:Rats; D015398:Signal Transduction / Q000502:physiology*
D002518:Ceramides; D005230:Fatty Acids, Nonesterified; D007328:Insulin; C541449:PMI-5011; D010936:Plant Extracts; D006003:Glycogen; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; C516610:Ptpn1 protein, rat